Talk:Schott Pharma
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||
|
Some additional references
editHi fellow Wikipedians,
Whilst I was looking for additional sources for this article, I came across the following that are yet to be cited within the text. Please feel to use these if you feel they are helpful:
https://www.sueddeutsche.de/wirtschaft/schott-corona-impfung-pharma-boerse-1.5722401
https://transkript.de/artikel/2022/schott-gliedert-pharma-glaeser-aus-und-plant-ipo/
https://cleanroomtechnology.com/schott-eyes-new-plant-in-china-188687
https://www.pharmaceutical-technology.com/contractors/commercial-packaging/schott-packaging/
Governance / “needs expansion” templates
editHi, I was wondering if anyone could provide the reasoning behind the "needs expansion" templates. While I get why one might want to add historical financial results, I don't see the value of detailed lists of board members (especially true for parent company board and supervisory board members). This increases the risk of incorrect or outdated information.
To support my point, the first version is already wrong:
References
- ^ Cite error: The named reference
:4
was invoked but never defined (see the help page). - ^ Kolf, Ingo (2024-05-15). "Kurs bricht ein: Schott Pharma: Trübe Aussichten führen zu drastischem Kurseinbruch". FinanzNachrichten.de (in German). Retrieved 2024-06-24.
Almuth Steinkühler isn't part of the parent company’s board of directors, and she also isn't SCHOTT AG's CFO, but rather Schott Pharma's CFO. Hence, I moved the section here.
If there’s no guideline to keep it, I also suggest deleting the section “Independent Supervisory Board” and reconsidering the detailed list of production sites (which also both incomplete and regularly changing). Thanks for your input! Elisabeth at SCHOTT (talk) 10:47, 6 November 2024 (UTC)